Design and evaluation of taste masked chewable dispersible tablet of lamotrigine by melt granulation
Keywords:
Lamotrigine, Melt granulation, Precirol, Taste masking, Chewable dispersible tabletsAbstract
Lamotrigine, an antiepileptic drug (AED) of the phenyltriazine class, is chemically unrelated to existing antiepileptic drugs. Lamotrigine is also used in the treatment of depression and bipolar disorder. But it is a bitter drug and slightly soluble in water. Thus, in the work under taken, an attempt was made to mask the taste and to formulate into a chewable dispersible tablet by complexation with Precirol ATO-05, which also acts as taste masking agent. Since, these tablets can be swallowed in the form of dispersion; it is suitable dosage form for paediatric and geriatric patients. Drug-Precirol ATO-05 was prepared in drug to Precirol ATO-05 ratio of 1:2, 1:1.5, 1:1, 1:0.5. The prepared tablets were evaluated for general appearance, content uniformity, hardness, friability, taste evaluation, mouth feel, in vitro disintegration time, and in vitro dissolution studies. Tablets with Precirol ATO-05 have shown good disintegrating features, also, the dispersion not showing any bitter taste, indicate the capability of Precirol ATO-05 used, both as taste masking agents. Almost more than 90 percent of drug was released from the formulation within 1 h. Further formulations were subjected to stability testing for 3 months at temperatures 25±5ºC/60±5%RH; 30±5ºC/65±5%RH and 40±5ºC/75±5%RH. Tablets have shown no appreciable changes with respect to taste, disintegration, and dissolution profiles.
References
Roy G.M., Taste masking in oral pharmaceuticals,
Pharm. Tech. Eur. 1994;24–35.
Shimano K.; Kondo O.; Miwa A.; Higashi Y.;
Goto S.; Evaluation of uniform-sized
microcapsules using a vibration-nozzle method.
Drug Dev. Ind. Pharm. 1995; 21; 331–347.
Lu M.Y.F.; Borodkin S.; Woodward L.; Li P.;
Diesner C.; Hernandez L.; Vadnere M.;. A
polymer carrier system for taste masking of
macrolide antibiotics. Pharm. Res. 1991; 8; 706–
Motola S.; Agisim G.R.; Mogavero A.;. Palatale
ibuprofen solutions. ; 1991; US Patent 5,024,997.
Blase C.M.; Shaw; M.N.; Aqueous
pharmaceutical suspensions for pharmaceutical
actives. 1993; EP application no. O556057 B1 to
McNeil-PPC Inc.
Appelgren C.; Eskilson; C.; Novel method for the
granulation and coating of pharmacologically
active substance. Drug. Dev. Ind. Pharm. 1990;
; 2345–2351.
Lachman, Liberman HA, Anig JL. Theory and
practice of industrial pharmacy. 3rd ed. Mumbai:
Varghese Publishing House; 1991. p. 296-302.
Bi Y, Sunada H; Yonezawa Y; Danjo K; Otsuka
A; Iida K.; Preparation and evaluation of a
compressed tablet rapidly disintegrating in the
oral cavity; Chem Pharm Bull (Tokyo) 1996;
:2121-7.
Nanda AR; Kandarapu Garg S.; An update on
taste masking technologies for oral
pharmaceuticals. Indian J Pharm Sci; 2002;64:10-
’
Hanawa T; Watanabe A; Tsuchiya T; Ikoma R;
Hidaka M; Sugihara M.; New oral dosage form
for elderly patients: preparation and
characterization of silk fibroin gel. Chem. Pharm
Bull (Tokyo). 1995; 43: 284-288.
Schaefer T. Melt agglomeration with polyethylene
glycols in high shear mixer. Ph.D. thesis, The
Royal Danish School of Pharmacy, Denmark.
Thies R.; Kleinebudde P; Melt pelletisation of a
hygroscopic drug in a high shear mixer. Part 1.
Influence of process variables; Int. J. Pharm.
; 188; 131–143.
Zhou F.; Vervaet; C.; Remon J.P.; Matrix pellets
on the combination of waxes, starches and
maltodextrins. Int. J. Pharm. 1996; 133; 155–160.
Voinovich D.; Moneghini M.; Perissutti B.;
Filipovic-Grcic,J.; Grabnar I.; Preparation in highshear mixer of sustained-release pellets by melt
pelletisation. Int. J. Pharm. 2000; 203, 235–244.
Perissutti B.; Voinovich D.; Moneghini M.;
Franceschinis E.; A powerful technique to prepare
in a single step potential sustained release dosage
forms: melt pelletisation in high shear mixer. In:
Fourth World Meeting on Pharmaceutics
Biopharmaceutics Pharmaceutical Technology,
Florence. 2002b.
Satoskar RS; Bhandakar SD and Ainapure SS:
Pharmacology and Pharmacotherapeutics, 17th
Edition .Popular Prakashan, Mumbai. 2001: 353-
Jaimini M; Rana AC; Tanwar YS.; Formulation
and Evaluation of Famotidine Floating Tablets.
Current Drug Delivery 2007; 4: 51-55.
Hiremath JG; Shastry CS; Srinath MS.;
Pharmaceutical approaches of taste masking in
oral dorage forms. Indian Drugs 2004; 41:253-7.
Sayed MS; Ulviya G; Bajaj AN.; Oral controlled
release Bromohexine ion exchange resinate
suspension formulation. Indian Drugs; 2000:185-
Sreenivas S. A; Gadad A. P; “Formulation and
evaluation of Ondancetron Hcl directly
compressed mouth disintegrating tablets.” Indian
Drugs, 2006, 43,:35-38.
Kajiyama A.; Tamura T.; Mizumoto T.; Kawai
H.; Takahashi T.; Quick disintegrating tablet in
buccal cavity and manufacturing method thereof.
December 2, 2003;US Patent 6,656,492
.Available from:
http://www.venpetro.com/Ambroxol
hydrochloride. RO - CEP 2004-240-Rev 00.
Devarajan S. S.; Lakshmi; “Simultaneous
spectrophotometer determination of Valdecoxib
and Tizanidine in tablets” Indian J Pharm Sci;
68:240-242.